The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), which attempts to standardize reporting and cytological criteria for fine-needle aspiration (FNA) of thyroid nodules and was ...

The Bethesda system for reporting thyroid cytology classifies nodules that undergo FNA into six groups of varying malignant potential: I (nondiagnostic), II (benign), III (atypia or follicular ...

Review updates in the 2023 Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) Recognize cytomorphology patterns of thyroid FNA Identify pitfalls and challenges in thyroid FNA cytology ...

originally identified as Bethesda III, according to The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). In addition to showing that 55% of reexamined nodules were found to be benign ...

The ultrasound features were assessed based on scans preceding a thyroid biopsy. Cytology results were classified according to the Bethesda system. The nature of the thyroid nodule was determined on ...

Changes in the World Health Organization classification of thyroid tumors can influence reliability of cytology. The 2023 Bethesda System for Reporting Thyroid Cytopathology has adapted ...

Changes in the World Health Organization classification of thyroid tumors can influence reliability of cytology. The 2023 Bethesda System for Reporting Thyroid Cytopathology has adapted ...

Management of large thyroid nodules over 4 cm that are ... Overall, 47 nodules over 4 cm and Bethesda II cytology were included, with an average follow-up of 5 years (range 2.2 to 9.7 years).

Please provide your email address to receive an email when new articles are posted on . Researchers obtained thyroid FNA samples from Beth Israel Deaconess Medical Center that were submitted for ...

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), first introduced in 2010, offers a standardized, category-based reporting framework. This system, widely adopted globally ...